ProPhase Labs Inc (NASDAQ:PRPH) price on Friday, May 23, rose 4.36% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.32.
A look at the stock’s price movement, the close in the last trading session was $0.31. Turning to its 52-week performance, $5.45 and $0.22 were the 52-week high and 52-week low respectively. Overall, PRPH moved -4.42% over the past month.
ProPhase Labs Inc’s market cap currently stands at around $13.31 million, with investors looking forward to this quarter’s earnings report slated for in June.
Analysts have a consensus estimate of 3.55M for the company’s revenue for the quarter, with a low and high estimate of 3.55M and 3.55M respectively. The average forecast suggests up to a 43.49% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 21.36M, representing a 214.08% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that PRPH is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 0 recommend PRPH as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Hold which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
PRPH’s current price about -1.85% and -6.55% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 48.23, while 7-day volatility ratio is 9.02% and 7.81% in the 30-day chart. Further, ProPhase Labs Inc (PRPH) has a beta value of -0.50, and an average true range (ATR) of 0.06. Analysts have given the company’s stock an average 52-week price target of $14, forecast between a low of $14 and high of $14. Looking at the price targets, the low is -4275.0% off current price level while to achieve the yearly target high, price needs to move -4275.0%. Nonetheless, investors will most likely welcome a -4275.0% jump to $14 which is the analysts’ median price.
If we refocus on ProPhase Labs Inc (NASDAQ:PRPH), historical trading data shows that trading volumes averaged 2.29 million over the past 3 months. The company’s latest data on shares outstanding shows there are 41.54 million shares.
The 11.73% of ProPhase Labs Inc’s shares are in the hands of company insiders while institutional holders own 12.02% of the company’s shares. Current price change has pushed the stock -57.68% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the PRPH stock continues to rise going into the next quarter.
